101
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Serum HSV-1 and -2 IgM in Pregnant Women in Port Harcourt, Nigeria

, , &

REFERENCES

  • Pena, K.C.; Adelson, M.E.; Mordechai, E.; Blaho, J.A. Rapid Isolation of HSV-1 and HSV-2 from OneSwab® Cervicovaginal Specimens. J. Virol. Meth. 2009, 159, 146–151.
  • Cusini, M.; Ghislanzoni, M. The Importance of Diagnosing Genital Herpes. J Antimicrob. Chemother. 2001, 47(Suppl T1), 9–16.
  • Smith, J.S.; Robinson, N.J. Age-Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review. J. Infect. Dis. 2002, 186, S3–28.
  • Haddow, L.J.; Dave, B.; Mindel, A.; McPhie, K.A.; Chung, C.; Marks, C.; Dwyer, D.E. Increase in Rates of Herpes Simplex Virus Type 1 as a Cause of Anogenital Herpes in Western Sydney, Australia, between 1979 and 2003. Sex. Transm. Infect. 2006, 82, 255–259.
  • Roizman, B.; Knipe, D.M.; Whitley, R.J. Herpes Simplex Viruses. In Virology, 5th ed.; Knipe, D.M., Howley, P.M., Eds.; Lippincott-Raven: Philadelphia, 2007, pp. 2501–2602.
  • Kriebs, J.M. Understanding Herpes Simplex Virus: Transmission, Diagnosis, and Considerations in Pregnancy Management. J. Midwifery Womens Health 2008, 53, 202–208.
  • Baker, D.A. Consequences of Herpes Simplex Virus in Pregnancy and Their Prevention. Curr. Opin. Infect. Dis. 2007, 20, 73–76.
  • Sauerbrei, A.; Wutzler, P. Herpes Simplex and Varicella-Zoster Virus Infections during Pregnancy: Current Concepts of Prevention, Diagnosis and Therapy. Part 1: Herpes Simplex Virus Infections. Med. Microbiol. Immunol. 2007, 196, 89–94.
  • Rathore, S.; Jamwal, A.; Gupta, V. Herpes Simplex Virus Type 2: Seroprevalence in Antenatal Women. Ind. J STD & AIDS 2010, 31, 11–15.
  • Whitley, R.J.; Roizman, B. Herpes Simplex Viruses. Lancet 2001, 357, 1513–1518.
  • Anzivino, E.; Fioriti, D.; Mischitelli, M.; Bellizzi, A.; Barucca, V.; Chiarini, F.; Pietropaolo, V. Herpes Simplex Virus Infection in Pregnancy and in Neonate: Status of Art of Epidemiology, Diagnosis, Therapy and Prevention. Virol. J. 2009, 6, 40–46.
  • Straface, G.; Selmin, A.; Zanardo, V.; De Santis, M.; Ercoli, A.; Scambia, G. Herpes Simplex Virus Infection in Pregnancy. Infect. Dis. Obstet.Gynecol. 2012, 1–6.
  • Centers for Disease Control and Prevention. Sexually transmitted disease guidelines. Morbidity and Mortality Weekly Report 2010, 59(RR-12), 1–116. Retrieved from: http://www.cdc.gov/std/treatment/2006/rr5511.pdf (accessed April 5, 2014).
  • Enright, A.M.; Prober, C.G. Neonatal Herpes Infection, Diagnosis, Treatment and Prevention. Sem. Fetal Neonat. Med. 2002, 7, 283–291.
  • Chen, K.T.; Segú, M.; Lumey, L.H.; Kuhn, L.; Carter, R.J.; Bulterys, M.; Abrams, E.J. New York City Perinatal AIDS Collaborative Transmission Study (PACTS) Group: Genital Herpes Simplex Virus Infection and Perinatal Transmission of human immunodeficiency virus. Obstet. Gynecol. 2005, 106, 1341–1348.
  • Corey, L.; Adams, H.G.; Brown, Z.A.; Holmes, K.K. Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications. Ann. Intern. Med. 1983, 98, 958–972.
  • Madhavan, H.N.; Priya, K.; Bagyalakshmi, R. 2003. Phenotypic and Genotypic Methods for the Detection of Herpes Simplex Virus Serotypes. J. Virol. Meth. 2003, 108, 97–102.
  • Brown, Z.A.; Selke, S.; Zeh, J.; Kopelman, J.; Maslow, A.; Ashley, R.L.; Watts, D.H.; Berry, S.; Herd, M.; Corey, L. The Acquisition of Herpes Simplex Virus during Pregnancy. New Engl. J. Med. 1997, 337(8), 509–515.
  • Malkin, J.E.; Morand, P.; Malvy, D.; Ly, T.D.; Chanzy, B. De Labareyre, C.; El Hasnaoui, A.; Hercberg, S. Seroprevalence of HSV-1 and HSV-2 Infection in the General French Population. Sex. Transm. Infect. 2002, 78, 201–203.
  • Kasubi, M.J.; Nilsen, A.; Marsden, H.S.; Bergström, T.; Langeland, N.; Haarr, L. Prevalence of Antibodies against Herpes Simplex Virus Types 1 and 2 in Children and Young People in an Urban Region in Tanzania. J. Clin. Microbiol. 2006, 44(8), 2801–2807.
  • Abdul Mohymen, N.; Hussien, A.; Hassan, F.K. Association between TORCH Agents and Recurrent Spontaneous Abortion. Iraqi J. Med. Sci. 2009, 7, 40–46.
  • AL–Taie AAD. Serological Study For TORCH Infections In Women With High Delivery Risk Factors In Mosul. Tikrit J. Pure Sci. 2010, 15, 193–198.
  • Jasim, M.; Majeed, H.A.; Ali, A.I. Performance of Serological Diagnosis of TORCH Agents in Aborted versus Non Aborted Women of Waset Province in Iraq. Tikrit Med. J. 2011, 17(2), 141–147.
  • Aljumaili, Z.K.M.; Alsamarai, A.M.; Najem, W.S. Seroprevalence of Herpes Simplex Virus Type 2 (HSV 2) in Women with Bad Obstetric History, Amer. J. Dermatol. Venerol. 2013, 2(3),31–38.
  • Ozdemir, R.; Er, H.; Baran, N.; Vural, A. and Demirci, M. HSV-1 and HSV-2 Seropositivity Rates in Pregnant Women Admitted to Izmir Ataturk Research and Training Hospital, Turkey. Bull. Mikrobiyol. 2006, 43(4), 709–711.
  • Sadik, M.S.; Fatima, H.; Jamil, K.; Patil, C. Study of TORCH Profile in Patients with Bad Obstetric History. Biol. Med. 2012, 4(2), 95–101.
  • Alzahrani, A.J.; Obeid, O.E.; Almulhim, A.A.; Awari, B.; Taha, A. et al. Analysis of Herpes Simplex 1 and 2 IgG and IgM Antibodies in Pregnant Women and their Neonates. Saudi J. Obstet. Gynaecol. 2005, 5, 53–57.
  • Ozdemir, M.; Kalem, F.; Feyzioglu, B.; Bysal, B. Investigation of Viral Pathogen during Pregnancy in a City Region in Turkey. Anatol. J. Clin. Invest. 2011, 5, 78–81.
  • Vilibik-Cavlek, T.; Ljubin-Sternak, S.; Ban, M.; Kolaric, B.; Sviben, M.; Mlinaric-Galinovic, G. Seroprevalence of TORCH Infections in Women of Childbearing Age in Croatia. J. Matern. Fetal Neonat. Med. 2011, 24(2), 280–283.
  • Nabi, S.N.; Wasey, A.; Haider, K.M.T.S.; Khan, A.A.; Hoque, M.M. Seroprevalen of TORCH Antibody in Pregnant Women. J. Armed Forces Med. Coll. 2012, 8, 35–39.
  • Turbadkar, D.; Mathur, M.; Rele, M. Seroprevalence of TORCH Infection in Bad Obstetric History. Ind. J. Med. Microbiol. 2003, 21, 108–111.
  • Surpam, R.B.; Kamlakar, U.P.; Khadse, R.K.; Qazi, M.S.; Jalgaonkar, S.V. Serological Study for TORCH Infections in Women with Bad Obstetric History. J. Gynecol. Obstet. India 2006, 56, 41–43.
  • Gumber, S.; Arora, U.; Devi, P. Occurrence of Cytomegalovirus and Herpes Simplex Virus Infections in Pregnancy. Ind. J. Med. Microbiol. 2008, 26, 204–205.
  • Haider, M.; Rizvi, M.; Khan, N.; Malik, A. Serological Study of Herpes Virus Infection in Female Patients with Bad Obstetric History. Biol. Med. 2011, 3(2, Special Issue), 284–290.
  • Tada, D.G.; Khandelwal, N. Serum HSV-1 and 2 IgM in Patients of Sexually Transmitted Diseases. Ann. Trop. Med. Public Health 2012, 5, 479–482
  • Al-Marzoqi, A.H.M.; Kadhim, R.A.; Aljanabi, D.K.F.; Hussein, H.J.; Al Tae, Z.M. Seroprevalence Study of IgG and IgM Antibodies to Toxoplasma, Rubella, Cytomegalovirus, Chlamydia Trachomatis and Herpes Simplex II in Pregnancy Women in Babylon Province. J. Biol. Agricult. Healthcare 2012, 2, 159–164.
  • Abu-Madi, M.A.; Behnke, J.M.; Dabritz, H.A. Toxoplasma Gondii Seropositivity and Co-Infection with TORCH Pathogens in High-Risk Patients from Qatar. Amer. J. Trop. Med. Hyg. 2010, 82(4), 626–633.
  • Ghazi, H.O.; Telmesani, A.M.; Mahomed, M.F. Torch Agents in Pregnant Saudi Women. Med. Princ. Pract. 2002, 11(4),180–190. Jasim M, Majeed HA, Ali AI. Performance of Serological Diagnosis of TORCH Agents in Aborted versus Non Aborted Women of Waset Province in Iraq. Tikrit Med. J. 2011, 17(2), 141–147.
  • Dordević, H. Serological Response to Herpes Simplex Virus Type 1 and 2 Infection among Women of Reproductive Age. Medicinski Pregled. 2006, 59(11–12), 591–597.
  • Duran, N.; Fugen, Y.; Cuneyt, E.; Fatih, K. Asymptomatic Herpes Simplex Virus Type 2 (HSV-2) Infection among Pregnant Women in Turkey. Ind. J. Med. Res. 2004, 120, 106–110.
  • Beydoun, H.A.; Dail, J.; Ugwu, B.; Boueiz, A.; Beydoun, M.A. Socio-demographic and Behavioral Correlates of Herpes Simplex Virus Type 1 and 2 Infections and Co-Infections among Adults in the USA. Int. J. Infect. Dis. 2010, 14S3, e154–e160.
  • Adelson, M.E.; Feola, M.; Trama, J.; Tilton, R.C.; Mordechai, E. Simultaneous Detection of Herpes Simplex Virus Types 1 and 2 by Real-Time PCR and Pyrosequencing. J. Clin. Virol. 2005, 33, 25–34.
  • Aggarwal, A.; Kaur, R. Seroprevalence of Herpes Simplex Virus-1 and 2 Antibodies in STD Clinic Patients. Ind. J. Med. Microbiol. 2004, 22, 244–246.
  • Santos, F.C.; de Oliveira, S.A.; Setúbal, S.; Camacho, L.A.; Faillace, T.; Leite, J.P.; Velarde, L.G. Seroepidemiological Study of Herpes Simplex Virus Type 2 in Patients with the Acquired Immunodeficiency Syndrome in the City of Niterói, Rio de Janeiro, Brazil. Mem. Instit. Oswaldo Cruz 2006, 101, 315–319.
  • Choudhry, S.; Ramachandran, V.G.; Das, S.; Bhattacharya, S.N.; Mogha, N.S. Serological Profile of HSV-2 in Patients Attending STI Clinic: Evaluation of Diagnostic utility of HSV-2 IgM Detection. Ind. J. Pathol. Microbiol. 2009, 52, 353–356.
  • Wald, A.; Huang, M.L.; Carrell, D.; Selke, S.; Corey, L. Polymerase Chain Reaction for Detection of Herpes Simplex Virus (HSV) DNA on Mucosal Surfaces: Comparison with HSV Isolation in Cell Culture. J. Infect. Dis. 2003, 188, 1345–1351.
  • Wals, A. Herpes Simplex Virus Type 2 Transmission: Risk Fators and Virus Sheeding. Herpes 2004, 11(Suppl 3), 130A–6.
  • Adekunle, A.; Sule, W.F.; Oluwayelu, D.O. High Negativity of IgG Antibodies against Human Papillomavirus Type 6, 11, 16 and 18 Virus-like Particles in Healthy Women of Childbearing Age. J. Exper. Integr. Med. 2014, 4(1), 37–41.
  • Okonko, I.O.; Ofoedu, V.; Okerentugba, P.O.; Njoku, H.O. Seroepidemiology and High Negativity of IgG Antibodies against Human Papillomavirus (HPV) Type 6, 11, 16 and 18 Virus-Like Particles in Women of Childbearing Age in Port Harcourt, Nigeria. J. Immunass. Immunochem. 2014, 36(2), 210–220.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.